Product

Ketorolac Tromethamine

Aliases
ketorolac, Ketorolac Tromethamine 15 MG/ML, NTM-001 (Ketorolac Tromethamine IV Continuous Infusion), Toradol
Name
Ketorolac Tromethamine
INN Name
Ketorolac Tromethamine
FDA Approved
Yes

11 clinical trials

44 organizations

31 indications

6 documents

Indication
Pain
Indication
Postoperative
Indication
Gout
Indication
Gout Flare
Indication
Anesthesia
Indication
Analgesic
Indication
Obstetric
Indication
Ketorolac
Indication
Hemorrhage
Indication
Abdominal Pain
Indication
Migraine
Indication
Urolithiasis
Indication
Biliary Colic
Indication
Abdomen
Indication
Acute
Indication
Appendicitis
Indication
Emergencies
Indication
Pediatric
Indication
Only
Indication
Back Pain
Indication
Chronic Pain
Clinical trial
Pharmacokinetics of Anesthetics and Analgesics in Children and Adolescent
Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Prospective Evaluation of the Effects of IV Ketorolac on Platelet Function Post-Cesarean Delivery
Status: Active (not recruiting), Estimated PCD: 2022-02-03
Organization
STAT RX USA LLC
Organization
Proficient Rx LP
Organization
Civica, Inc.
Organization
WOCKHARDT LIMITED
Organization
MICRO LABS LIMITED
Organization
Nephron SC Inc.
Organization
Wockhardt USA LLC.
Organization
DIRECT RX
Organization
Eugia US LLC
Organization
Apotex Corp.
Organization
Asclemed USA, Inc.
Organization
Hospira, Inc.
Organization
Bionpharma Inc.
Organization
IT3 Medical LLC
Organization
RedPharm Drug Inc.
Organization
Henry Schein, Inc.
Organization
REMEDYREPACK INC.